Compare Range Nuclear Renaissance ETF (NUKZ) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Range Nuclear Renaissance ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Range Nuclear Renaissance ETF trades at $61.06 (market cap $698.21M), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.63 (market cap $2.27B). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 3.3× Range Nuclear Renaissance ETF's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals.
| NUKZ | SLS | |
|---|---|---|
Market Cap | $698.21M | $2.27B |
Volume | 57,444 | 4,179,659 |
Sector | Sector/Thematic | Health |
52-Week High | $76.23 | $15.46 |
52-Week Low | $60.23 | $1.39 |
Typical Hold Time | 17 Days | — |
Enterprise Value | — | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Range Nuclear Renaissance ETF
Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
